Therapeutic area
Infectious Disease
Viral, bacterial, fungal, and parasitic infections, and preventative vaccines and therapeutics.
Core & active disease programs
Provisional & emerging programs (13)Early clinical pipeline & single-asset indications
Respiratory Syncytial Virus Infection
Recurrent Respiratory Papillomatosis
Anthrax
Clostridioides Difficile Infection
COVID-19
Cryptococcal Meningitis
Helicobacter pylori Infection
Hepatitis Delta
Herpes Simplex Virus Infection
Human Papillomavirus Infection
Infectious Disease
Molluscum Contagiosum
Poxvirus Infections